Phase II Study with Docetaxel and Cisplatin in the Treatment of Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck

Publisher： Karger

E-ISSN： 1423-0232|63|2|145-150

ISSN： 0030-2414

Source： Oncology, Vol.63, Iss.2, 2002-09, pp. : 145-150

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phase II Study of Cetuximab in Combination with Docetaxel in Patients with Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck after Platinum-Containing Therapy: A Multicenter Study of the Arbeitsgemeinschaft Internistische Onkologie

By  

Oncology, Vol. 84, Iss. 5, 2013-02 ,pp. : 284-289

Karger

Access to resources Recommend Favorite

Vinorelbine and Carboplatin in Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck

By  

Oncology, Vol. 56, Iss. 1, 1999-01 ,pp. : 24-27

Karger

Access to resources Recommend Favorite

RASSF1A and ERCC1 Expression Levels Might Be Predictive of Prognosis in Advanced, Recurrent, and Metastatic Squamous Cell Carcinoma of the Head and Neck Treated with Docetaxel and Cisplatin

By  

Oncology Research and Treatment, Vol. 35, Iss. 11, 2012-10 ,pp. : 673-682

Karger

Access to resources Recommend Favorite

Cisplatin, Raltitrexed, Levofolinic Acid and 5-Fluorouracil in Locally Advanced or Metastatic Squamous Cell Carcinoma of the Head and Neck: A Phase II Randomized Study

By  

Oncology, Vol. 63, Iss. 3, 2002-10 ,pp. : 232-238

Karger

Access to resources Recommend Favorite

Phase II study of bevacizumab in combination with docetaxel and radiation in locally advanced squamous cell carcinoma of the head and neck

By  

HEAD & NECK: JOURNAL FOR THE SCIENCES & SPECIALTIES OF THE HEAD AND NECK, Vol. 37, Iss. 11, 2015-11 ,pp. : 1665-1671

John Wiley & Sons Inc

Access to resources Recommend Favorite